The Allstate Co. (NYSE:ALL) Position Increased by CX Institutional

CX Institutional grew its position in shares of The Allstate Co. (NYSE:ALL) by 20.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,829 shares of the insurance provider’s stock after buying an additional 5,173 shares during the quarter. CX Institutional’s holdings in Allstate were worth $5,944,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. SPC Financial Inc. grew its stake in shares of Allstate by 3.6% during the third quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock worth $297,000 after purchasing an additional 54 shares during the period. Lake Street Advisors Group LLC grew its position in shares of Allstate by 1.8% during the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock worth $596,000 after buying an additional 54 shares during the period. Abacus Planning Group Inc. increased its stake in shares of Allstate by 2.4% in the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after acquiring an additional 56 shares during the last quarter. Chicago Partners Investment Group LLC raised its position in shares of Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after acquiring an additional 59 shares during the period. Finally, Carmichael Hill & Associates Inc. boosted its stake in Allstate by 15.0% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock worth $87,000 after acquiring an additional 60 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Trading Up 0.1 %

ALL stock opened at $184.89 on Friday. The stock has a market cap of $48.96 billion, a price-to-earnings ratio of 11.98, a price-to-earnings-growth ratio of 1.41 and a beta of 0.52. The company has a fifty day moving average price of $195.15 and a two-hundred day moving average price of $187.10. The Allstate Co. has a one year low of $153.42 and a one year high of $209.88. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s revenue was up 14.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.81 EPS. Equities analysts anticipate that The Allstate Co. will post 16.83 EPS for the current year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were issued a dividend of $0.92 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.99%. Allstate’s payout ratio is currently 23.83%.

Wall Street Analysts Forecast Growth

ALL has been the topic of a number of recent analyst reports. UBS Group lifted their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Piper Sandler boosted their price objective on shares of Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research report on Tuesday, November 26th. Evercore ISI raised shares of Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their price target on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $218.13.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.